Adrienne Scheck, PhD, is an associate professor of neurobiology at Barrow Neurological Institute.
Dr. Scheck’s expertise includes neuro-oncology. She is a member of the American Association for Cancer Research, Society for Neuro-Oncology, American Society for Biochemistry and Molecular Biology, Women in Cancer Research, and the American Association for the Advancement of Science.
Dr. Scheck received her doctorate in biology from Rensselaer Polytechnic Institute and completed her postdoctoral fellowship at Penn State Health Milton S. Hershey Medical Center.
Dr. Scheck’s research interests include metabolic alteration, specifically the ketogenic diet, as an adjunct therapy to the standard of care to improve survival and minimize side effects for patients with malignant brain tumors.
- Postdoctoral Fellowship, Milton S. Hershey Medical Center, Penn State University College of Medicine, 1981-1986
- PhD, Rensselaer Polytechnic Institute, 1980
- BA, University of Rochester, 1976
- American Association for Cancer Research
- Society for Neuro-Oncology
- American Society for Biochemistry and Molecular Biology
- Women in Cancer Research
- American Association for the Advancement of Science
- 50 Most Influential Women in Arizona Business, AZ Business Magazine, 2013
- Researcher Finalist, AZ Business Magazine Health Care Leadership Awards, 2013
- Oncology Specialist, Matthews Friends Scientific Advisory Board
- Researcher and Scientist of the Year, YWCA Tribute to Women, 1998
- Lussier DM, Woolf EC, Johnson JL, Brooks KS, Blattman JN, Scheck AC. Enhanced immunity in a malignant glioma model is mediated by a therapeutic ketogenic diet. BMC Cancer. 2016;16:310.
- Woolf EC, Scheck AC. The ketogenic diet for the treatment of malignant glioma. J Lipid Res. 2015;56(1):5-10.
- Woolf EC, Curley KL, Liu Q, Turner GH, Charlton JA, Preul MC, Scheck AC. The ketogenic diet alters the hypoxic response and affects expression of proteins associated with angiogenesis, invasive potential and vascular permeability in a mouse glioma model. PLoS One. 2015;10(6):e0130357.
- Fenton KE, Martirosyan NL, Abdelwahab MG, Coons SW, Preul MC, Scheck AC. In vivo visualization of GL261-luc2 mouse glioma cells by use of Alexa Fluor-labeled TRP-2 antibodies. Neurosurg Focus. 2014;36(2):E12.
- Scheck AC, Abdelwahab MG, Fenton KE, Stafford P. The ketogenic diet for the treatment of glioma: insights from genetic profiling. Epilepsy Res. 2012;100(3):327-337.
- Hughes AK, Cichacz Z, Scheck A, Coons SW, Johnston SA, Stafford P. Immunosignaturing can detect products from molecular markers in brain cancer. PLoS One. 2012;7(7):e40201.
- Abdelwahab MG, Fenton KE, Preul MC, Rho JM, Lynch A, Stafford P, Scheck AC. The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS One. 2012;7(5):e36197.
- Abdelwahab MG, Sankar T, Preul MC, Scheck AC. Intracranial implantation with subsequent 3D in vivo bioluminescent imaging of murine gliomas. J Vis Exp. 2011(57):e3403.
- Stafford P, Abdelwahab MG, Kim DY, Preul MC, Rho JM, Scheck AC. The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. Nutr Metab (Lond). 2010;7:74.
- Smith R, Smith KA, Biggs CA, Scheck AC. In vitro biological dosimeter modeling of the glioblastoma response to radiation delivered by the Gamma Knife. Laboratory investigation. J Neurosurg. 2010;113 Suppl:222-227.